US20070208062A1 - 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections - Google Patents

3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections Download PDF

Info

Publication number
US20070208062A1
US20070208062A1 US11/569,150 US56915005A US2007208062A1 US 20070208062 A1 US20070208062 A1 US 20070208062A1 US 56915005 A US56915005 A US 56915005A US 2007208062 A1 US2007208062 A1 US 2007208062A1
Authority
US
United States
Prior art keywords
compound
formula
mmol
pharmaceutically
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/569,150
Inventor
Daniel Carcanague
Michael Gravestock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0411595A priority Critical patent/GB0411595D0/en
Priority to GB0411595.2 priority
Priority to GB0500056A priority patent/GB0500056D0/en
Priority to GB0500056.7 priority
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to PCT/GB2005/002059 priority patent/WO2005116024A1/en
Assigned to ASTRAZENECA AB reassignment ASTRAZENECA AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRAVESTOCK, MICHAEL BARRY, CARCANAGUE, DANIEL ROBERT
Publication of US20070208062A1 publication Critical patent/US20070208062A1/en
Abandoned legal-status Critical Current

Links